Aptevo Therapeutics Inc. ( APVO) - Stock Earnings
APVO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.8 million USD | -220000 USD |
| 2026Q1 | -6.7 million USD | — USD |
| 2026Q2 | -6.4 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
APVO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -17.4 million USD | — USD |
| 2024 | -24.1 million USD | — USD |
| 2025 | -26.0 million USD | — USD |
| 2026 Est. | — | — |
APVO
Price: $2.90
52 week price:
Earnings Per Share: 1488.13 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 73389
Ebitda: -9.5 millionMarket Capitalization: 4.5 million